Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32940638.
- Also identified by DOI 10.1001/jamaoncol.2020.4408 and PMC identifier 7499239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This prospective observational study assesses changes in treatment plans for patients with lung cancer and qualifies the types of changes observed as a direct result of the coronavirus disease 2019 pandemic.
Medical subject headings
- COVID-19
- Carcinoma, Non-Small-Cell Lung
- Delivery of Health Care
- Lung Neoplasms
- Medical Oncology
- Small Cell Lung Carcinoma